Long Naps, Daytime Sleepiness Tied To Greater Risk Of Metabolic Syndrome:
Articles by Medical News
Signs Of Stress In The Brain May Signal Future Heart Trouble,
New research shows that individuals with a greater degree of activity in the stress center of the brain also have more evidence of inflammation in their arteries and were at higher risk for cardiovascular events, including heart attack, stroke and death, according to a study scheduled for presentation at the American College of Cardiology’s 65th Annual Scientific Session.
Biomedical engineering researchers at North Carolina State University and the University of North Carolina at Chapel Hill have developed a technique that uses a patch embedded with microneedles to deliver cancer immunotherapy treatment directly to the site of melanoma skin cancer. In animal studies, the technique more effectively targeted melanoma than other immunotherapy treatments.
Ultraslim graphene sensor monitors blood sugar levels through skin,
A wearable, graphene-based patch could one day maintain healthy blood glucose levels in people by measuring the sugar in sweat and then delivering the necessary dose of a diabetes drug through the skin
Curcumin May Help Overcome Drug-Resistant Tuberculosis,
New research indicates that curcumin–a substance in turmeric that is best known as one of the main components of curry powder–may help fight drug-resistant tuberculosis.
Toxoplasmosis may alter brain chemistry is people exhibiting bouts of explosive anger:
Researchers Develop Innovative Blood Test To Predict Risk Of Developing The Tuberculosis Disease:
New guidelines ask women to hold off on pregnancy for 8 weeks and men to wait 6 months:
Temple Scientists Eliminate HIV-1 From Genome Of Human T-Cells,
Building on their groundbreaking research, Temple University scientists make another breakthrough in a potential cure for HIV.
The U.S. Food and Drug Administration today issued a draft guidance intended to support industry in their development of generic versions of approved opioids with abuse-deterrent formulations (ADF) while ensuring that generic ADF opioids are no less abuse-deterrent than the brand-name drug. Today’s actions are among a number of steps the agency recently outlined in an action plan to reassess its approach to opioid medications. The plan is focused on policies aimed at reversing the epidemic, while still providing patients in pain access to effective relief.